序贯加压装置对门诊整形手术患者纤溶活性的随机试验
该随机试验纳入50例全静脉麻醉下美容手术门诊患者,比较术中使用小腿序贯加压装置与不使用对血浆tPA和PAI-1水平的影响。结果显示两组各时间点纤溶指标均无显著变化,无深静脉血栓发生,提示序贯加压装置无全身纤溶获益。
要点
- 门诊整形手术全静脉麻醉下全身纤溶活性无显著变化。
- 序贯加压装置未影响tPA或PAI-1水平,无纤溶获益。
- 所有患者均无深静脉血栓的临床或超声证据。
核心结论
- 门诊整形手术全静脉麻醉期间全身纤溶活性无显著变化,序贯加压装置不影响tPA或PAI-1水平,提示无纤溶获益。
研究设计与样本
- 随机试验纳入50例连续门诊整形美容手术患者,全静脉麻醉无肌松,随机分为术中使用小腿序贯加压装置组或不使用组。
- 术前及术后每小时取上肢血样至离开麻醉后监护室,检测tPA和PAI-1水平,所有患者行超声监测。
主要发现
- 所有患者同意参与,纳入率100%。
- 无患者出现深静脉血栓的临床征象或超声证据。
- tPA和PAI-1水平从术前测量至各小时 interval 均无显著变化,使用与不使用序贯加压装置的患者间水平无差异。
临床怎么用
- 门诊整形手术全静脉麻醉下序贯加压装置可能不提供额外纤溶保护,临床决策应基于其他预防机制。
局限性
- 研究仅纳入50例门诊美容手术患者,全静脉麻醉无肌松,结果可能不适用于其他手术类型或麻醉方式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sequential compression devices are often considered a mainstay of prophylaxis against deep venous thromboses in surgical patients. The devices are believed to produce a milking action on the deep veins to prevent venous stasis. A systemic fibrinolytic effect has also been proposed, adding a second mechanism of action. The plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 reflect fibrinolytic activity. METHODS: A randomized trial was conducted among 50 consecutive plastic surgery outpatients undergoing cosmetic surgery performed by the author under total intravenous anesthesia and without paralysis. Patients were randomized to receive calf-length sequential compression devices or no sequential compression devices during surgery. Blood samples were obtained from the upper extremity preoperatively and at hourly intervals until the patient was discharged from the postanesthesia care unit. Tissue plasminogen activator and plasminogen activator inhibitor-1 levels were measured. Ultrasound surveillance was used in all patients. There was no outside funding for the study. RESULTS: All patients agreed to participate (inclusion rate, 100 percent). No patient developed clinical signs or ultrasound evidence of a deep venous thrombosis. There were no significant changes in tissue plasminogen activator levels or plasminogen activator inhibitor-1 levels from the preoperative measurements at any hourly interval and no differences in levels comparing patients treated with or without sequential compression devices. CONCLUSIONS: No significant change in systemic fibrinolytic activity occurs during outpatient plastic surgery under total intravenous anesthesia. Sequential compression devices do not affect tissue plasminogen activator or plasminogen activator inhibitor-1 levels, suggesting no fibrinolytic benefit. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, I.
引用
- Swanson E. The Effect of Sequential Compression Devices on Fibrinolysis in Plastic Surgery Outpatients: A Randomized Trial. Plast Reconstr Surg. 2020. PMID: 31985629. doi:10.1097/PRS.0000000000006464
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。